Company Precipio, Inc.

Stocks

PRPO

US74019L6020

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 00:00:00 12/09/2026 +04			5-day change	1st Jan Change
27.32 ^USD	+1.52%		-0.29%	+18.89%

08-18	Precipio, Inc., Q2 2026 Earnings Call, Aug 17, 2026
08-15	Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Business description: Precipio, Inc.

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Companyâ€™s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Companyâ€™s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.

Number of employees: 66

Sales by Activity: Precipio, Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Healthcare Facilities & Services	8.85M	9.41M	15.2M	18.53M	24.05M

See all business segments

Geographical breakdown of sales: Precipio, Inc.

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
United States	8.85M	9.41M	15.2M	18.53M	24.05M

See all geographic segments

Executive Committee: Precipio, Inc.

Manager	Title	Age	Since
Ahmed Zaki Sabet COO	Chief Operating Officer	41	-
Ayman Mohamed CTO	Chief Tech/Sci/R&D Officer	42	01/06/2017
Ilan Danieli CEO	Chief Executive Officer	54	28/06/2017
Matthew Gage DFI	Director of Finance/CFO	59	21/03/2022
Miri Chiko-Radomski HRO	Human Resources Officer	-	-

See PRECIPIO, INC. governance

Composition of the Board of Directors: Precipio, Inc.

Director	Title	Age	Since
Ilan Danieli BRD	Director/Board Member	54	28/06/2017
Jeffrey Cossman BRD	Director/Board Member	78	26/09/2017
David Cohen BRD	Director/Board Member	67	08/11/2017
Kathleen LaPorte BRD	Director/Board Member	64	09/08/2018
Richard Sandberg CHM	Chairman	83	01/03/2021
Ron Andrews BRD	Director/Board Member	66	01/03/2021
Christina Valauri BRD	Director/Board Member	70	01/01/2024

Composition of the Board of Directors

Shareholders: Precipio, Inc.

Name	Stocks	%	Valuation
AMH Equity Ltd. 8.861 %	158,635	8.861 %	4 M $
David Eklund 4.706 %	84,250	4.706 %	2 M $
David Cohen 3.083 %	55,199	3.083 %	2 M $
Vanguard Capital Management LLC 2.578 %	46,148	2.578 %	1 M $
Richard Sandberg 2.019 %	36,142	2.019 %	1 M $

List of PRECIPIO, INC. shareholders

Company details: Precipio, Inc.

Precipio, Inc.

4 Science Park

06511, New Haven

+203 787 7888

http://www.precipiodx.com

Medical Diagnostic & Testing Equipment

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PRECIPIO, INC.	+1.52%	-0.29%	+40.10%	+363.05%	48.91M
SARTORIUS AG	+0.87%	-1.81%	+20.83%	-28.73%	16.73B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-1.77%	+5.22%	-35.05%	+55.90%	1.75B
ECKERT & ZIEGLER SE	+0.08%	-4.28%	-28.36%	+24.66%	893M
QUIDELORTHO CORPORATION	-3.05%	-15.68%	-58.77%	-84.02%	808M
VAREX IMAGING CORPORATION	-0.05%	-0.27%	+63.36%	-1.86%	778M
CONTEC MEDICAL SYSTEMS CO.,LTD	-2.56%	-5.17%	-38.85%	-50.56%	637M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-5.26%	-9.59%	-43.32%	-52.47%	560M
REVENIO GROUP OYJ	+3.41%	-14.92%	-44.30%	-37.49%	450M
CELLAVISION AB	+2.02%	+0.62%	-7.77%	-7.88%	397M
Average	-0.48%	-4.34%	-13.21%	+18.06%	2.31B
Weighted average by Cap.	+0.30%	-2.06%	+8.40%	-21.43%